Blog
06-29-2017
FDA
FDA HIV Update: Approval of Generic Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 200 mg/300 mg - Blog
FDA Requests Removal of Opana ER for Risks Related to Abuse 06-29-2017Crossposted from FDA Newsroom Note: Earlier this month, the FDA requested that a drug company remove an opioid pain medication, Opana ER, from the market becau.… - Blog
FDA Requests Removal of Opana ER for Risks Related to Abuse 06-29-2017 - Blog
Health Information on the Web 03-07-2017Millions of consumers are using digital media to get health information, applications to monitor health conditions, and social media to find people who share s.…